|
|
.gif) |
|
Back To Happy And Healthy Life . .
. | |
|
|
| |
|
The
Best Place To Find The Cheapest Propecia
|
|
| |
.gif) | |
On compute you, these enterprises took up yourselves approximately 16 individual projects at the same time, with average total expenditure per the project average, which exceeds $18 million. Over the 30-Jahrezeitraum central expenditures per project doubled approximately (P. 1041). In addition there was a broad product range duration and ran from 1 to 26 years, although or smaller took 90% from them 10 years. As expects, projects that, which a new application(NDA)were do not produce drug become skillful, which is early concluded, when that one led to NDAs. Their primary results were based on logit recovery models, which were used, in order to explain the probability of the project of success, in success by a new application of drugs were indicated. Their describing main-variable are: Scale - the total expenditure development of the enterprise, range - the number in those therapeutic categories firmwas actively and experience - the supply reached NDAs.When, before are together in the estimating equation, the scale effect enclosed, was not not statistic meaning this describing variables, while the range effect has a noticeable effect on the probability of the success of the project. The enterprise behind success in the therapeutic category was also substantial and positive associatedwith successful results. The authors state that "shifting the average project would increase the probability of success to an enterprise, which is active in a wider range by approximately 0,03" (P. 20).However, find them also that both of these maintained effects disappear, if firm substitute symbol variables are introduced to the analysis, from which them state that "much the change of the range range between instead of within enterprises" is (P. 20). The different ways, in which research is organized as between enterprises in the Henderson Cockburn sample, to have remarkable effects on the probability of success. The authors notice the presence "of bearing the idiosynkratischen differences under enterprises in the organization and the management drug development of the process. . Differences concerning the development strategy - in the step and in the TIMING of the development expenditure and in the formulation of the research strategy, the clinical development lead - [ can be ], important determining factors of development productivity "(P. 21). This summary raises the question of, why less efficient organizations and managements continue and not by more effective alternatives is replaced. Pair of overalls, Cockburn and Henderson (1999) emphasize the presence knowledge of overflowing within and over the enterprises. The success of a given project, argue it, increased by the success in connection of a program within the enterprise as well as in other enterprises. Even more importantly, they write: |